Tim Corson, PhD
Dr. Corson is the Merrill Grayson Senior Associate Professor and Director of Basic and Translational Research in the Eugene and Marilyn Glick Eye Institute and Departments of Ophthalmology, Biochemistry and Molecular Biology, and Pharmacology and Toxicology at Indiana University School of Medicine in Indianapolis, Indiana. After growing up in Australia, England, New Zealand, and Canada, he completed BSc, MSc and PhD degrees at the University of Toronto, where he studied genetic changes in the eye cancer, retinoblastoma. Subsequently, as the Canadian Institutes of Health Research Jean-François St-Denis Fellow in Cancer Research at Yale University, he learned to apply chemical biology approaches (the use of chemicals to probe biological systems) to diverse disease-related problems. In his own laboratory, he applies these techniques to mechanistic and therapeutic studies of antiangiogenic natural products and their derivatives, with the goal of developing new therapies for diseases of abnormal blood vessel growth such as AMD and ocular tumors. He has published more than 50 papers and filed 8 patents. In addition to the BrightFocus Foundation, his work has been supported by the International Retinal Research Foundation, the Retina Research Foundation, and the National Institutes of Health.